SWOT Analysis for Gyre Therapeutics Inc

Buy Zone: Stocks in the buy zone based on days traded at current PE and P/BV
Annual Profit Growth higher than Sector Profit Growth
Increasing Revenue every quarter for the past 2 quarters
Top Gainers
Biggest Price Gainers from Open

PEG greater than Industry PEG
Bearish Stocks - Stocks with Medium to Low Trendlyne Momentum Score
High PE (PE > 40)
Low DVM Stocks - Stocks to Exercise Caution On
Lowest Momentum Scores (Technical Scores)
Stocks with Expensive Valuations according to the Trendlyne Valuation Score
Low durability companies
Weak Stocks (DVM)
Highest fall from 52 Week High
Near 52 Week Low
Low Piotroski Score : Companies with weak financials
Declining Net Cash Flow : Companies not able to generate net cash
Weak performer : Stock lost more than 20% in 1 month
Weak Momentum: Price below Short, Medium and Long Term Averages
Declining profits every quarter for the past 3 quarters
Profit to Loss Companies
RSI indicating price weakness
Stocks Underperforming their Industry Price Change in the Quarter